Houston, TX, United States of America

Irwin H Krakoff


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1991-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Irwin H Krakoff: Innovator in Antitumor Platinum Complexes

Introduction

Irwin H Krakoff is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of chemistry, particularly in the development of platinum complexes with antitumor activity. His work has the potential to impact cancer treatment significantly.

Latest Patents

Krakoff holds 2 patents, with his latest inventions focusing on 1,2-diaminocyclohexane-platinum complexes. These complexes are designed for the treatment of tumors in animals. The invention involves a process that utilizes water-soluble square-planar cis platinum(II) four-coordinate complexes. These complexes comprise various nonovalent and divalent organic cations, which include galacturonato and N,N-dimethylglycinato as monovalent cations, and citraconato, 1,1-cyclobutanedicarboxylato, 1,1-cyclopropanedicarboxylato, and Z-iminodiacetato as divalent cations. The treatment method involves administering a pharmaceutical composition containing these platinum complexes to animals.

Career Highlights

Krakoff is affiliated with the University of Texas System, where he continues to engage in research and development. His work is characterized by a commitment to advancing medical science through innovative chemical solutions.

Collaborations

Throughout his career, Krakoff has collaborated with esteemed colleagues, including Abdul R Khokhar and Robert A Newman. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Irwin H Krakoff's contributions to the field of chemistry, particularly in the area of antitumor treatments, highlight his role as an influential inventor. His innovative work with platinum complexes showcases the potential for significant advancements in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…